Mercaptopurine and bilirubin conjugated increased Patient Reports February 09, 2010

Mercaptopurine Side Effects Report #5104911-3
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2006. Female patient, weighting 179.9 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aggression, alanine aminotransferase increased, ammonia increased, amnesia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, dizziness . Mercaptopurine dosage: 3100 MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, NEURONTIN. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #5115660-X
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, weighting 172.4 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, cholelithiasis, dehydration, diarrhoea. Mercaptopurine dosage: 11449 MG SEE IMAGE. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, VINCRISTINE SULPHATE. Patient recovered.

Mercaptopurine Side Effects Report #5179136-6
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Female patient, weighting 86.64 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood glucose increased. Mercaptopurine dosage: 15960 MG. During the same period patient was treated with METHOTREXATE, THIOGUANINE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #5648022-7
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 29, 2008. Male patient, weighting 249.6 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, hepatic cirrhosis, ill-defined disorder, iron overload, transaminases increased. Mercaptopurine dosage: 5800 MG. During the same period patient was treated with VINCRISTINE SULPHATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.


Mercaptopurine Side Effects Report #6050563-8
Mercaptopurine side effect was reported by a Consumer or non-health professional from NEW ZEALAND on Jan 22, 2009. Female patient, weighting 108.0 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, bilirubin conjugated increased, blood bilirubin increased, culture positive, fluid overload, gallbladder disorder, hepatic function abnormal, hepatic vein occlusion. Mercaptopurine dosage: 3600 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, PENTAMIDINE. Patient was hospitalized. Patient recovered.